2025 HCPCS Code Q2040

Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion

TAGS: viable preparation leukapheresis million infusion
NoticeHCPCS Q2040 terminated on December 31, 2018.
Short DescriptionTisagenlecleucel car-pos t
HCPCS Action Code N - No maintenance for this code
HCPCS Coverage Code C - Carrier judgment
HCPCS Code Added Date January 01, 2018
HCPCS Action Effective Date January 01, 2019
HCPCS Pricing Indicator Code 51 - Drugs
HCPCS Type Of Service Code 1 - Medical care
HCPCS Multiple Pricing Indicator Code A - Not applicable as HCPCS priced under one methodology
HCPCS Anesthesia Base Unit Quantity 0
HCPCS Coverage Issues Manual Reference Section Number

Check Similar HCPCS Codes